Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc...
IU Simon Cancer Center's Komen Tissue Bank Collecting Samples June 25
6/09/2011
Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 8:30 a.m. to 2:30 p.m. Saturday, June 25, in the Hematology Clinic and Women's Center (second floor) in the patient building of the Indiana University Melvin and Bren Simon Cancer Center, 1030 W. Michigan St...
Simple Blood Test Could Speed Up Cancer Drug Development
6/09/2011
Cancer drug development could accelerate in the future thanks to a simple and quick blood test that can help reveal the effectiveness of a new treatment, according to research presented this week at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago...
FDA Approves Trial Of Adamis Pharmaceuticals Product Candidate To Treat Prostate Cancer
6/09/2011
Adamis Pharmaceuticals Corporation (OTCBB: ADMP) announced today that the FDA has accepted an Investigational New Drug (IND) application for APC-100 to treat prostate cancer (PCa). Adamis plans to begin Phase 1/2a clinical studies with APC-100 in men with castrate resistant prostate cancer (CRPR)...
New Chronic Myelogenous Leukemia Guidelines For Patients Available From NCCN
6/09/2011
The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation, recently announced the latest addition to the library of NCCN Guidelines for Patients™, the NCCN Patient Guidelines™ for Chronic Myelogenous Leukemia...
Combination Of Cancer Marker RECAF And CA125 Can Be Used For Ovarian Cancer Screening
6/09/2011
BioCurex Inc. (OTCBB: BOCX - News) today announced the publication of the article entitled: 'Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer' in a peer reviewed scientific journal specialized in cancer markers. Ovarian cancer is called the silent killer because most patients have no symptoms until the tumor becomes very large and it has already spread...
Alliance Optimizes Design Of Cancer Trials To Provide Best Patient Outcomes
6/09/2011
TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today. "The highest quality medical imaging provided by Imaging Endpoints is one more weapon in TD2's arsenal," said Dr...
New 3-D Tumor Model - A Step Toward Speeding Cancer Drug Research
6/09/2011
A team of scientists has developed a way to coax tumor cells in the lab to grow into 3-D spheres. Their discovery takes advantage of an earlier technique of producing spherical cavities in a common polymer and promises more accurate tests of new cancer therapies. As team leader Michael R. King, Ph.D...
The University of Alabama at Birmingham has taken a significant step toward making sophisticated cell therapy a part of patient care with its acquisition of the first cell-processing workstation (CPWS) from SANYO North America Corporation (SANYO) in the United States. Richard Marchase, Ph.D...
Allium Medical Solutions Ltd. Is Granted A Japanese Patent For Its Triangular Prostatic Stent
6/09/2011
Allium Medical Solutions Ltd., the developer and manufacturer of innovative, site-specific stents for the urinary, biliary and gastro-intestinal systems, announced that it has been granted a patent by the Japanese Patent Office for its application named "STENT". The filing refers to the unique design of its Triangular Prostatic Stent (TPS)...